US Appeals Court Backs Dismissal Of Bystolic ‘Pay-For-Delay’ Case
Verdict Comes Despite FTC Opposition To Nebivolol Agreements Involving Generics Firms
Executive Summary
The US Court of Appeals for the Second Circuit has backed up a US district court decision to dismiss purchaser and payer claims linked to so-called “pay-for-delay” agreements with generics firms over nebivolol rivals to Bystolic.